3-(5-Benzyl-1,3,4-oxadiazol-2-yl)-1-(2-morpholin-4-ylethyl)-1H-indole
3-(5-Benzyl-1,3,4-oxadiazol-2-yl)-1-(2-morpholin-4-ylethyl)-1H-indole | |
4-(2-(3-(5-benzyl-1,3,4-oxadiazol-2-yl)-1H-indol-1-yl)ethyl)morpholine | |
Synthetic cannabinoids | |
Synthetic cannabinoid receptor agonists | |
|
|
|
InChI=1S/C23H24N4O2/c1-2-6-18(7-3-1)16-22-24-25-23(29-22)20-17-27(21-9-5-4-8-19(20)21)11-10-26-12-14-28-15-13-26/h1-9,17H,10-16H2
|
JDSYHOBFNKNECV-UHFFFAOYSA-N
|
|
N1(CCN2CCOCC2)C=C(C3=NN=C(CC4=CC=CC=C4)O3)C5=C1C=CC=C5
|
|
C23H24N4O2 | |
388.4623 g/mol |